Antigen-specific therapy using apoptotic bodies enhances treg cells in autoimmunity, suggesting its clinical potential in MS.
Our findings indicate that antigen-specific therapy with PS liposomes mimicking apoptotic bodies downregulates the MOG-specific inflammatory immune response and expands Breg and Treg cells, offering a safe, versatile, and easily applicable approach that strongly supports its potential for near-future clinical translation in MS.
No takes yet. Share an insight, caveat, or question.
Marta Vives‐Pi (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: